Literature DB >> 25288091

Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.

Arnold S Bayer1, Nagendra N Mishra1, George Sakoulas2, Poochit Nonejuie3, Cynthia C Nast4, Joseph Pogliano3, Kuan-Tsen Chen5, Steven N Ellison5, Michael R Yeaman6, Soo-Jin Yang7.   

Abstract

Over the past several years, single-nucleotide polymorphisms (SNPs) within the mprF open reading frame (ORF) have been proposed to be associated with a gain-of-function phenotype in terms of daptomycin (DAP) nonsusceptibility (referred to as daptomycin resistance [DAP-R] herein for ease of presentation) in Staphylococcus aureus. We investigated the frequencies of SNPs within the mprF ORF and the relationships of such SNPs to cross-resistance between DAP and cationic host defense peptides (HDPs). Thirty-five well-characterized, unique DAP-susceptible (DAP-S) and DAP-R methicillin-resistant S. aureus (MRSA) isolates of the clonal complex 5 genotype were used. In addition to mprF SNPs and DAP-HDP cross-resistance, several other key genotypic and phenotypic metrics often associated with DAP-R were delineated, as follows: (i) mprF expression, (ii) membrane phospholipid content, (iii) positive surface charge, (iv) DAP binding, and (v) cell wall thickness profiles. A number of DAP-S strains (MICs of ≤ 1 μg/ml) exhibited mprF SNPs, occasionally with high-level mprF sequence variation from the genotype reference strain. However, none of these SNPs were localized to well-chronicled mprF hot spot locations associated with DAP-R in S. aureus. In contrast, all 8 DAP-R isolates demonstrated SNPs within such known mprF hot spots. Moreover, only the DAP-R strains showed MprF gain-of-function phenotypes, enhanced mprF expression, higher survival against two prototypical HDPs, and reduced DAP binding. Although a heterogenous array of mprF SNPs were often found in DAP-S strains, only selected hot spot SNPs, combined with concurrent mprF dysregulation, were associated with the DAP-R phenotype.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25288091      PMCID: PMC4249560          DOI: 10.1128/AAC.03422-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection.

Authors:  Clare E Miller; Rahul Batra; Ben S Cooper; Amita K Patel; John Klein; Jonathan A Otter; Theodore Kypraios; Gary L French; Olga Tosas; Jonathan D Edgeworth
Journal:  Clin Infect Dis       Date:  2011-12-20       Impact factor: 9.079

2.  VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus.

Authors:  Shrenik Mehta; Arabela X Cuirolo; Konrad B Plata; Sarah Riosa; Jared A Silverman; Aileen Rubio; Roberto R Rosato; Adriana E Rosato
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

3.  Changes in genetic lineages, resistance, and virulence in clinical methicillin-resistant Staphylococcus aureus in a Spanish hospital.

Authors:  Carmen Lozano; Nerea Porres-Osante; Julien Crettaz; Beatriz Rojo-Bezares; Daniel Benito; Inés Olarte; Myriam Zarazaga; Yolanda Sáenz; Carmen Torres
Journal:  J Infect Chemother       Date:  2012-10-03       Impact factor: 2.211

4.  Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance.

Authors:  Soo-Jin Yang; Nagendra N Mishra; Aileen Rubio; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2013-09-03       Impact factor: 5.191

5.  Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus.

Authors:  Nagendra N Mishra; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

6.  Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients.

Authors:  Nagendra N Mishra; Arnold S Bayer; Pamela A Moise; Michael R Yeaman; George Sakoulas
Journal:  J Infect Dis       Date:  2012-08-16       Impact factor: 5.226

Review 7.  Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall.

Authors:  Arnold S Bayer; Tanja Schneider; Hans-Georg Sahl
Journal:  Ann N Y Acad Sci       Date:  2012-12-05       Impact factor: 5.691

8.  Characterization of the Staphylococcus aureus mprF gene, involved in lysinylation of phosphatidylglycerol.

Authors:  Yusuke Oku; Kenji Kurokawa; Norikazu Ichihashi; Kazuhisa Sekimizu
Journal:  Microbiology       Date:  2004-01       Impact factor: 2.777

9.  Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.

Authors:  A Peschel; R W Jack; M Otto; L V Collins; P Staubitz; G Nicholson; H Kalbacher; W F Nieuwenhuizen; G Jung; A Tarkowski; K P van Kessel; J A van Strijp
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

10.  Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms.

Authors:  Nagendra N Mishra; Soo-Jin Yang; Liang Chen; Claudette Muller; Azzam Saleh-Mghir; Sebastian Kuhn; Andreas Peschel; Michael R Yeaman; Cynthia C Nast; Barry N Kreiswirth; Anne-Claude Crémieux; Arnold S Bayer
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more
  30 in total

Review 1.  Mechanisms of drug resistance: daptomycin resistance.

Authors:  Truc T Tran; Jose M Munita; Cesar A Arias
Journal:  Ann N Y Acad Sci       Date:  2015-10-23       Impact factor: 5.691

2.  Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.

Authors:  Rachel E Jenson; Sarah L Baines; Benjamin P Howden; Nagendra N Mishra; Sabrina Farah; Cassandra Lew; Andrew D Berti; Sanjay K Shukla; Arnold S Bayer; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

3.  Dysregulation of mprF and dltABCD expression among daptomycin-non-susceptible MRSA clinical isolates.

Authors:  Arnold S Bayer; Nagendra N Mishra; Ambrose L Cheung; Aileen Rubio; Soo-Jin Yang
Journal:  J Antimicrob Chemother       Date:  2016-04-27       Impact factor: 5.790

4.  β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.

Authors:  Jordan R Smith; Katie E Barber; Animesh Raut; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

5.  Impact of Exposure of Methicillin-Resistant Staphylococcus aureus to Polyhexanide In Vitro and In Vivo.

Authors:  A Renzoni; E Von Dach; C Landelle; S M Diene; C Manzano; R Gonzales; W Abdelhady; C P Randall; E J Bonetti; D Baud; A J O'Neill; A Bayer; A Cherkaoui; J Schrenzel; S Harbarth; P François
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

6.  Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus.

Authors:  Y Iwata; K Satou; H Tsuzuku; K Furuichi; Y Senda; Y Sakai-Takemori; T Wada; S Fujita; T Miyake; H Yasuda; N Sakai; S Kitajima; T Toyama; Y Shinozaki; A Sagara; T Miyagawa; A Hara; M Shimizu; Y Kamikawa; S Kaneko; T Wada
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-05-05       Impact factor: 3.267

7.  Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics.

Authors:  Andrew D Berti; Sarah L Baines; Benjamin P Howden; George Sakoulas; Victor Nizet; Richard A Proctor; Warren E Rose
Journal:  Antimicrob Agents Chemother       Date:  2015-03-02       Impact factor: 5.191

Review 8.  Mechanisms of resistance to antimicrobial peptides in staphylococci.

Authors:  Hwang-Soo Joo; Michael Otto
Journal:  Biochim Biophys Acta       Date:  2015-02-17

9.  Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.

Authors:  Kristoffer T Bæk; Louise Thøgersen; René G Mogenssen; Maiken Mellergaard; Line E Thomsen; Andreas Petersen; Søren Skov; David R Cameron; Anton Y Peleg; Dorte Frees
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

10.  Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.

Authors:  Arnold S Bayer; Nagendra N Mishra; Liang Chen; Barry N Kreiswirth; Aileen Rubio; Soo-Jin Yang
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.